Literature DB >> 18443089

Hemolysin of uropathogenic Escherichia coli evokes extensive shedding of the uroepithelium and hemorrhage in bladder tissue within the first 24 hours after intraurethral inoculation of mice.

Yarery C Smith1, Susan B Rasmussen, Kerian K Grande, Richard M Conran, Alison D O'Brien.   

Abstract

Many uropathogenic Escherichia coli (UPEC) strains produce both hemolysin (Hly) and cytotoxic necrotizing factor type 1 (CNF1), and the loci for these toxins are often linked. The conclusion that Hly and CNF1 contribute to urovirulence is supported by the results of epidemiological studies associating the severity of urinary tract infections (UTIs) with toxin production by UPEC isolates. Additionally, we previously reported that mouse bladders and rat prostates infected with UPEC strain CP9 exhibit a more profound inflammatory response than the organs from animals challenged with CP9cnf(1) and that CNF1 decreases the antimicrobial activities of polymorphonuclear leukocytes. More recently, we created an Hly mutant, CP9Delta hlyA(1)::cat, and showed that it was less hemolytic and destructive for cultured bladder cells than CP9 was. Here we evaluated the relative effects of mutations in hlyA(1) or cnf(1) alone or together on the pathogenicity of CP9 in a mouse model of ascending UTI. To do this, we constructed an hlyA(1)-complemented clone of CP9Delta hlyA(1)::cat and an hlyA(1) cnf(1) CP9 double mutant. We found that Hly had no influence on bacterial colonization of the bladder or kidneys in single or mixed infections with the wild type and CP9Delta hlyA(1)::cat but that it did provoke sloughing of the uroepithelium and bladder hemorrhage within the first 24 h after challenge. Finally, we confirmed that CNF1 expression induces bladder inflammation and, in particular, as shown in this study, submucosal edema. From these data, we speculate that Hly and CNF1 may be largely responsible for the signs and symptoms of cystitis in humans infected with toxigenic UPEC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18443089      PMCID: PMC2446707          DOI: 10.1128/IAI.00075-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  61 in total

Review 1.  The interaction between RTX toxins and target cells.

Authors:  E T Lally; R B Hill; I R Kieba; J Korostoff
Journal:  Trends Microbiol       Date:  1999-09       Impact factor: 17.079

2.  Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli.

Authors:  M A Mulvey; Y S Lopez-Boado; C L Wilson; R Roth; W C Parks; J Heuser; S J Hultgren
Journal:  Science       Date:  1998-11-20       Impact factor: 47.728

3.  Deamidation of Cdc42 and Rac by Escherichia coli cytotoxic necrotizing factor 1: activation of c-Jun N-terminal kinase in HeLa cells.

Authors:  M Lerm; J Selzer; A Hoffmeyer; U R Rapp; K Aktories; G Schmidt
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

Review 4.  Rho GTPases and the actin cytoskeleton.

Authors:  A Hall
Journal:  Science       Date:  1998-01-23       Impact factor: 47.728

Review 5.  Rho proteins: targets for bacterial toxins.

Authors:  K Aktories
Journal:  Trends Microbiol       Date:  1997-07       Impact factor: 17.079

6.  Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine.

Authors:  G Flatau; E Lemichez; M Gauthier; P Chardin; S Paris; C Fiorentini; P Boquet
Journal:  Nature       Date:  1997-06-12       Impact factor: 49.962

7.  Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1.

Authors:  G Schmidt; P Sehr; M Wilm; J Selzer; M Mann; K Aktories
Journal:  Nature       Date:  1997-06-12       Impact factor: 49.962

8.  Urovirulence determinants in Escherichia coli strains causing prostatitis.

Authors:  A Andreu; A E Stapleton; C Fennell; H A Lockman; M Xercavins; F Fernandez; W E Stamm
Journal:  J Infect Dis       Date:  1997-08       Impact factor: 5.226

9.  Two pathogenicity islands in uropathogenic Escherichia coli J96: cosmid cloning and sample sequencing.

Authors:  D L Swenson; N O Bukanov; D E Berg; R A Welch
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

10.  Virulence characteristics of Escherichia coli in acute bacterial prostatitis.

Authors:  K Mitsumori; A Terai; S Yamamoto; S Ishitoya; O Yoshida
Journal:  J Infect Dis       Date:  1999-10       Impact factor: 5.226

View more
  57 in total

Review 1.  Host-pathogen interactions in urinary tract infection.

Authors:  Greta R Nielubowicz; Harry L T Mobley
Journal:  Nat Rev Urol       Date:  2010-07-20       Impact factor: 14.432

Review 2.  Invasion of Host Cells and Tissues by Uropathogenic Bacteria.

Authors:  Adam J Lewis; Amanda C Richards; Matthew A Mulvey
Journal:  Microbiol Spectr       Date:  2016-12

3.  Antibodies against hemolysin and cytotoxic necrotizing factor type 1 (CNF1) reduce bladder inflammation in a mouse model of urinary tract infection with toxigenic uropathogenic Escherichia coli.

Authors:  Mark A Smith; Rebecca A Weingarten; Lisa M Russo; Christy L Ventura; Alison D O'Brien
Journal:  Infect Immun       Date:  2015-02-09       Impact factor: 3.441

4.  Cytotoxic necrotizing factor type 1-neutralizing monoclonal antibody NG8 recognizes three amino acids in a C-terminal region of the toxin and reduces toxin binding to HEp-2 cells.

Authors:  Kerian K Grande; Karen C Meysick; Susan B Rasmussen; Alison D O'Brien
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

Review 5.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

6.  Chinese herb-resistance and adherence to human uroepithelial cells of uropathogenic Escherichia coli.

Authors:  YanQing Tong; Bing Xin; Ying Chi
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-11-02

7.  Identification of in vivo-induced antigens including an RTX family exoprotein required for uropathogenic Escherichia coli virulence.

Authors:  Patrick D Vigil; Christopher J Alteri; Harry L T Mobley
Journal:  Infect Immun       Date:  2011-03-21       Impact factor: 3.441

8.  Cytotoxic necrotizing factor 1 and hemolysin from uropathogenic Escherichia coli elicit different host responses in the murine bladder.

Authors:  Tamako A Garcia; Christy L Ventura; Mark A Smith; D Scott Merrell; Alison D O'Brien
Journal:  Infect Immun       Date:  2012-10-22       Impact factor: 3.441

Review 9.  The RTX pore-forming toxin α-hemolysin of uropathogenic Escherichia coli: progress and perspectives.

Authors:  Travis J Wiles; Matthew A Mulvey
Journal:  Future Microbiol       Date:  2013-01       Impact factor: 3.165

10.  A conserved PapB family member, TosR, regulates expression of the uropathogenic Escherichia coli RTX nonfimbrial adhesin TosA while conserved LuxR family members TosE and TosF suppress motility.

Authors:  Michael D Engstrom; Christopher J Alteri; Harry L T Mobley
Journal:  Infect Immun       Date:  2014-06-16       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.